Chr Hansen Holding A/S
CSE:CHR

Watchlist Manager
Chr Hansen Holding A/S Logo
Chr Hansen Holding A/S
CSE:CHR
Watchlist
Price: 549.6 DKK -0.61% Market Closed
Market Cap: 72.3B DKK
Have any thoughts about
Chr Hansen Holding A/S?
Write Note

Chr Hansen Holding A/S
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chr Hansen Holding A/S
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Chr Hansen Holding A/S
CSE:CHR
Operating Income
€358.3m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
6%
Novozymes A/S
CSE:NZYM B
Operating Income
kr4.5B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
N/A
P
Photocat A/S
STO:PCAT
Operating Income
-kr1.6m
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Chr Hansen Holding A/S
Glance View

Market Cap
72.3B DKK
Industry
Chemicals

Chr Hansen Holding A/S is a global leader in the natural ingredients market, specializing in the production of cultures, enzymes, and probiotics for various industries, including food, beverages, pharmaceuticals, and dietary supplements. Founded in 1874 and headquartered in Denmark, the company has established a solid reputation for its commitment to sustainability and innovation. With a focus on harnessing the power of nature, Chr Hansen's products enhance the quality, safety, and shelf life of food while promoting health through natural solutions. This strategic positioning not only supports a more sustainable food system but also aligns with the growing consumer demand for clean-label products and healthier choices. For investors, Chr Hansen presents a compelling opportunity, driven by its strong market presence and a portfolio of patented technologies that set it apart from competitors. The company benefits from a diverse customer base, serving major global brands as well as local businesses, and has demonstrated consistent revenue growth through strategic acquisitions and partnerships. With its investments in research and development, Chr Hansen is well-poised to capitalize on emerging trends in health and nutrition, making it a potential long-term investment for those seeking exposure to the burgeoning field of natural ingredients. As consumers become more aware of the health benefits of probiotics and natural food additives, Chr Hansen's unwavering focus on sustainability and innovation makes it a standout player in a competitive market.

CHR Intrinsic Value
382.12 DKK
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Chr Hansen Holding A/S's Operating Income?
Operating Income
358.3m EUR

Based on the financial report for Aug 31, 2023, Chr Hansen Holding A/S's Operating Income amounts to 358.3m EUR.

What is Chr Hansen Holding A/S's Operating Income growth rate?
Operating Income CAGR 10Y
6%

Over the last year, the Operating Income growth was 10%. The average annual Operating Income growth rates for Chr Hansen Holding A/S have been 3% over the past three years , 2% over the past five years , and 6% over the past ten years .

Back to Top